|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cookson MS, Roth BJ, Dahm P, Engstrom C,
Freedland SJ, Hussain M, Lin DW, Lowrance WT, Murad MH, Oh WK, et
al: Castration-resistant prostate cancer: AUA Guideline. J Urol.
190:429–438. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Willard SS and Koochekpour S: Regulators
of gene expression as biomarkers for prostate cancer. Am J Cancer
Res. 2:650–657. 2012.
|
|
4
|
Yang F, Li X, Sharma M, Zarnegar M, Lim B
and Sun Z: Androgen receptor specifically interacts with a novel
p21-activated kinase, PAK6. J Biol Chem. 276:15345–15353. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SR, Ramos SM, Ko A, Masiello D,
Swanson KD, Lu ML and Balk SP: AR and ER interaction with a
p21-activated kinase (PAK6). Mol Endocrinol. 16:85–99. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kaur R, Yuan X, Lu ML and Balk SP:
Increased PAK6 expression in prostate cancer and identification of
PAK6 associated proteins. Prostate. 68:1510–1516. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schrantz N, da Silva Correia J, Fowler B,
Ge Q, Sun Z and Bokoch GM: Mechanism of p21-activated kinase
6-mediated inhibition of androgen receptor signaling. J Biol Chem.
279:1922–1931. 2004. View Article : Google Scholar
|
|
8
|
Wen X, Li X, Liao B, Liu Y, Wu J, Yuan X,
Ouyang B, Sun Q and Gao X: Knockdown of p21-activated kinase 6
inhibits prostate cancer growth and enhances chemosensitivity to
docetaxel. Urology. 73:1407–1411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang M, Siedow M, Saia G and Chakravarti
A: Inhibition of p21-activated kinase 6 (PAK6) increases
radiosensitivity of prostate cancer cells. Prostate. 70:807–816.
2010.PubMed/NCBI
|
|
10
|
Ayub SG, Kaul D and Ayub T:
Microdissecting the role of microRNAs in the pathogenesis of
prostate cancer. Cancer Genet. 208:289–302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chua JH, Armugam A and Jeyaseelan K:
MicroRNAs: Biogenesis, function and applications. Curr Opin Mol
Ther. 11:189–199. 2009.PubMed/NCBI
|
|
12
|
Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z,
Li P, Zhang W, Wu H, Feng N, et al: miR-143 decreases prostate
cancer cells proliferation and migration and enhances their
sensitivity to docetaxel through suppression of KRAS. Mol Cell
Biochem. 350:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Epstein JI, Allsbrook WE Jr, Amin MB and
Egevad LL; ISUP Grading Committee: The 2005 International Society
of Urological Pathology (ISUP) Consensus Conference on Gleason
Grading of Prostatic Carcinoma. Am J Surg Pathol. 29:1228–1242.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feldman BJ and Feldman D: The development
of androgen-independent prostate cancer. Nat Rev Cancer. 1:34–45.
2001. View
Article : Google Scholar
|
|
15
|
Fang YX and Gao WQ: Roles of microRNAs
during prostatic tumorigenesis and tumor progression. Oncogene.
33:135–147. 2014. View Article : Google Scholar
|
|
16
|
McKee TC and Tricoli JV: Epigenetics of
prostate cancer. Methods Mol Biol. 1238:217–234. 2015. View Article : Google Scholar
|
|
17
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar :
|
|
18
|
Deng JH, Deng Q, Kuo CH, Delaney SW and
Ying SY: MiRNA targets of prostate cancer. Mol Biol Methods.
936:357–369. 2013. View Article : Google Scholar
|
|
19
|
Clapé C, Fritz V, Henriquet C, Apparailly
F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S and
Fajas L: miR-143 interferes with ERK5 signaling, and abrogates
prostate cancer progression in mice. PLoS One. 4:e75422009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Verdoodt B, Neid M, Vogt M, Kuhn V,
Liffers ST, Palisaar RJ, Noldus J, Tannapfel A and
Mirmohammadsadegh A: MicroRNA-205, a novel regulator of the
anti-apoptotic protein Bcl2, is downregulated in prostate cancer.
Int J Oncol. 43:307–314. 2013.PubMed/NCBI
|
|
21
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang W, Peng B, Wang D, Ma X, Jiang D,
Zhao J and Yu L: Human tumor microRNA signatures derived from
large-scale oligo-nucleotide microarray datasets. Int J Cancer.
129:1624–1634. 2011. View Article : Google Scholar
|
|
23
|
Malzkorn B, Wolter M, Liesenberg F,
Grzendowski M, Stühler K, Meyer HE and Reifenberger G:
Identification and functional characterization of microRNAs
involved in the malignant progression of gliomas. Brain pathol.
20:539–550. 2010. View Article : Google Scholar
|
|
24
|
Eiring AM, Harb JG, Neviani P, Garton C,
Oaks JJ, Spizzo R, Liu S, Schwind S, Santhanam R, Hickey CJ, et al:
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation
of mRNA translation in leukemic blasts. Cell. 140:652–665. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pan YZ, Morris ME and Yu AM: MicroRNA-328
negatively regulates the expression of breast cancer resistance
protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol.
75:1374–1379. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li WQ, Li YM, Tao BB, Lu YC, Hu GH, Liu
HM, He J, Xu Y and Yu HY: Downregulation of ABCG2 expression in
glioblastoma cancer stem cells with miRNA-328 may decrease their
chemoresistance. Med Sci Monit. 16:HY27–HY30. 2010.PubMed/NCBI
|
|
27
|
Dacic S, Kelly L, Shuai Y and Nikiforova
MN: miRNA expression profiling of lung adenocarcinomas: Correlation
with mutational status. Mod Pathol. 23:1577–1582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arora S, Ranade AR, Tran NL, Nasser S,
Sridhar S, Korn RL, Ross JT, Dhruv H, Foss KM, Sibenaller Z, et al:
MicroRNA-328 is associated with (non-small) cell lung cancer
(NSCLC) brain metastasis and mediates NSCLC migration. Int J
Cancer. 129:2621–2631. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Delic S, Lottmann N, Stelzl A, Liesenberg
F, Wolter M, Götze S, Zapatka M, Shiio Y, Sabel MC, Felsberg J, et
al: MiR-328 promotes glioma cell invasion via SFRP1-dependent
Wnt-signaling activation. Neuro-oncol. 16:179–190. 2014. View Article : Google Scholar :
|
